Vitrolife AB (publ) (LON:0YAY)
London · Delayed Price · Currency is GBP · Price in SEK 117.20
-0.60 (-0.51%)
At close: Feb 2, 2026
Vitrolife AB Revenue
In the year 2025, Vitrolife AB had annual revenue of 3.44B SEK, down -4.68%. Vitrolife AB had revenue of 892.00M in the quarter ending December 31, 2025, a decrease of -6.99%.
Revenue
3.44B SEK
Revenue Growth
-4.68%
P/S Ratio
3.68
Revenue / Employee
3.13M SEK
Employees
1,100
Market Cap
1.02B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | -169.00M | -4.68% |
| Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |